Apellis Pharmaceuticals (APLS)
(Delayed Data from NSDQ)
$35.63 USD
+0.10 (0.28%)
Updated Sep 18, 2024 04:00 PM ET
After-Market: $35.65 +0.02 (0.06%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/06/2024
Time: -- |
9/2024 | $-0.30 | -16.02% |
Earnings Summary
For their last quarter, Apellis Pharmaceuticals (APLS) reported earnings of -$0.28 per share, beating the Zacks Consensus Estimate of $-0.33 per share. This reflects a positive earnings surprise of 15.15%. Look out for APLS's next earnings release expected on November 06, 2024. For the next earning release, we expect the company to report earnings of -$0.30 per share, reflecting a year-over-year increase of 74.36%.
Earnings History
Price & Consensus
Zacks News for APLS
Acadia (ACAD) Up 10% Since Last Earnings Report: Can It Continue?
APLS: What are Zacks experts saying now?
Zacks Private Portfolio Services